Loading stock data…
Tenon Medical, Inc. (TNON)
$3.36-0.36 (-9.68%)
Market ClosedLast close Sep 8
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Tenon Medical, Inc. in the Healthcare sector is trading at $3.36 with a market capitalization of $2M. Wall Street consensus targets $44.38 (2 analysts), implying a +1220.7% move over the next 12 months. The stock is currently near its 52-week low of $3.18, remaining 85.7% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +1220.7% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.28M↓ | $1.38M↓ | $1.48M↑ | $1.17M↑ | $564,000 |
| Gross Profit | $814,000↓ | $945,000↓ | $1.02M↑ | $773,000↑ | $245,000 |
| Operating Income | -$3.35M↓ | -$3.28M↓ | -$2.87M↑ | -$3.39M↓ | -$2.86M |
| Net Income | -$4.05M↓ | -$3.48M↓ | -$2.83M↑ | -$3.34M↓ | -$2.77M |
Peer Comparison
JNJUNHPFE
Fundamentals
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.24M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.36
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
785.83%
Volume
Today's trading volume
385,357
Recent News
Tenon Medical (TNON) Q2 2026 Earnings Call Transcript
Record revenue and gross profit driven by surgical volume and system integration.
Tenon Medical Inc (TNON) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and FDA ...
Revenue surges 127% year-over-year to $1.3 million, with gross margin expanding to 64% and new FDA clearance for Catamaran system poised to further improve profitability.
Tenon Medical, Inc. Q2 2026 Earnings Call Summary
Moby summary of Tenon Medical, Inc.'s Q2 2026 earnings call
Tenon Medical Inc (TNON) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth ...
Tenon Medical Inc (TNON) reports a strong start to 2026 with record revenue and strategic investments despite challenges in operating expenses.
Tenon Medical, Inc. Q1 2026 Earnings Call Summary
Moby summary of Tenon Medical, Inc.'s Q1 2026 earnings call